AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said on Friday that the European Medicines Agency (EMA) endorsed ENHERTU for the ...

SRINAGAR: Director Animal Husbandry Kashmir, Dr. PS Sudan on Tuesday conducted a comprehensive review of the poultry sector in the region during his visit to the Poultry Project cum LPP ...

Median progression-free survival was 13.2 months with Enhertu compared with 8.1 months with chemotherapy. “The recent approval for Enhertu in patients that have HR-positive, and HER2-low or -ultralow ...

THE Department of Agrarian Reform (DAR) officially launched the Value Chain Innovation for Sustainable Transformation in Agrarian Reform Communities (Vista) to improve the livelihood of upland ...

Pakistan's Deputy Prime Minister Ishaq Dar has stated that 'if my advice had been followed in 2017, we wouldn't have had to beg for help for the next five years.' Addressing overseas Pakistanis in ...

AstraZeneca’s Enhertu (trastuzumab deruxtecan ... India’s Pharma Market Exceeds Rs 2.2 Lakh Crore, Growing at 8 Per Cent The Indian pharmaceutical market surpassed Rs 2.2 lakh crore in 2024, expanding ...

T.J. Otzelberger has a simple message for No. 8 Iowa State as it prepares to host Colorado in a Big 12 matchup Tuesday night in Ames, Iowa. The Cyclones' head coach told the players to keep up the ...

Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3,100 new brands collectively earned Rs 1,097 crore, with significant ...

Dar Al Arkan profit grows 9% to SAR 453.5M in 9M 2024; Q3 at SAR 134.7M 9 M 2024 Dar Al Arkan H1 2024 profit jumps 21% to SAR 318.7M; Q2 at SAR 165.1M 6 M 2024 Dar Al Arkan’s Q1 2024 profit jumps 31% ...

The Food and Drug Administration (FDA) has approved Enhertu ® (fam-trastuzumab deruxtecan ... in the trastuzumab deruxtecan arm and 8.1 months (95% CI, 7.0-9.0) in the chemotherapy arm.

In many ways, the Google Pixel 8a and Pixel 8 are so similar that they’re easy to compare. They share nearly identical displays, dimensions, software experiences, and update commitments ...